Stockscreener 앱 받기
38.26
0.17%
0.07
Cytokinetics Inc 주식(CYTK)의 최신 뉴스
Risk adjusted return profile for Cytokinetics Incorporated analyzedJuly 2025 Pullbacks & Safe Capital Growth Plans - Newser
When is the best time to exit Cytokinetics Incorporated2025 EndofYear Setup & Verified Trade Idea Suggestions - Newser
Cytokinetics Stock Price, Quotes and Forecasts | NASDAQ:CYTK - Benzinga
Pattern recognition hints at Cytokinetics Incorporated upsideWeekly Profit Analysis & Weekly Market Pulse Alerts - Newser
Should you hold or exit Cytokinetics Incorporated nowPortfolio Performance Report & Verified Chart Pattern Signals - Newser
How to manage a losing position in Cytokinetics IncorporatedRisk Management & Weekly Chart Analysis and Trade Guides - Newser
What the charts say about Cytokinetics Incorporated todayJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
Multi asset correlation models including Cytokinetics IncorporatedPortfolio Return Summary & Long-Term Capital Growth Ideas - Newser
What moving averages say about Cytokinetics IncorporatedJuly 2025 PreEarnings & Growth Focused Entry Point Reports - Newser
Cytokinetics Incorporated stock volume spike explained2025 Top Gainers & High Yield Stock Recommendations - Newser
What data driven models say about Cytokinetics Incorporated’s futureWeekly Trade Report & Community Consensus Picks - Newser
Visualizing Cytokinetics Incorporated stock with heatmapsPortfolio Risk Summary & Fast Entry Momentum Alerts - Newser
Cytokinetics Incorporated stock chart pattern explainedQuarterly Profit Report & Accurate Technical Buy Alerts - Newser
Cytokinetics Incorporated stock retracement – recovery analysisLong Setup & Weekly Return Optimization Plans - Newser
What’s next for Cytokinetics Incorporated stock priceShort Setup & Real-Time Chart Breakout Alerts - Newser
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cytokinetics, Incorporated (CYTK) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Can Cytokinetics Incorporated rally from current levelsJuly 2025 Volume & Fast Gain Swing Trade Alerts - Newser
Cytokinetics, Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
Cytokinetics to Present Positive Aficamten Results at ESC Congress 2025 with Investor Webcast Scheduled for September 2, 2025 - Quiver Quantitative
Major HCM Drug Trial Results: Cytokinetics' Aficamten vs Metoprolol Data Coming at ESC Congress 2025 - Stock Titan
Has Cytokinetics Incorporated formed a bullish divergenceJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Is Cytokinetics Incorporated affected by consumer sentiment2025 Top Gainers & High Accuracy Investment Signals - theviewers.co.kr
Is Cytokinetics Incorporated’s ROE strong enoughJuly 2025 Weekly Recap & Long-Term Safe Return Strategies - sundaytimes.kr
Is Cytokinetics Incorporated stock a good pick for beginnersJuly 2025 Review & Fast Moving Stock Trade Plans - theviewers.co.kr
Live Scanner Shows Breakout on Cytokinetics IncorporatedWall Street Watch & Community Driven Trade Alerts - 더경남뉴스
Sentiment analysis tools applied to Cytokinetics IncorporatedTrade Analysis Summary & Safe Capital Allocation Plans - Newser
Cytokinetics Appoints James M. Daly to Board of Directors - AInvest
Cytokinetics shares fall 1.35% intraday after appointing Jim Daly to Board of Directors. - AInvest
Acadian Asset Management Inc. shares fall 1.42% intraday after Cytokinetics appoints Jim Daly to Board of Directors. - AInvest
Cytokinetics Appoints James M. Daly to Board - TipRanks
Cytokinetics: Specialty Franchise With Aficamten And Ulacamten (NASDAQ:CYTK) - Seeking Alpha
Cytokinetics Names Jim Daly to Board of Directors - The Globe and Mail
Cytokinetics appoints James Daly to board of directors - Investing.com
Cytokinetics appoints James Daly to board of directors By Investing.com - Investing.com South Africa
Cytokinetics Appoints James Daly to Board with Commercialization Expertise. - AInvest
How to use Fibonacci retracement on Cytokinetics IncorporatedWeekly Trading Summary & Real-Time Volume Trigger Notifications - Newser
Will breakout in Cytokinetics Incorporated lead to full recovery2025 Price Targets & Community Consensus Picks - Newser
Cytokinetics Inc Announces Stock Options and RSUs for New Employees Amid Ongoing Cardiovascular Advancements - AInvest
How Efficient Is Cytokinetics Incorporated at Controlling Operating Costs2025 Price Momentum & Risk Managed Trade Strategies - Newser
Cytokinetics EVP Malik sells $76k in shares - Investing.com
Cytokinetics EVP Malik sells $76k in shares By Investing.com - Investing.com UK
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
105,169 Stock Options at $38.67: Cytokinetics Issues Major Employee Inducement Grants - Stock Titan
Cytokinetics Incorporated Inches Above Key Support — Safe to Hold2025 Volatility Report & High Return Trade Guides - 선데이타임즈
Will Cytokinetics Incorporated Recover After Recent DeclineJuly 2025 Analyst Calls & AI Driven Stock Movement Reports - newsimpact.co.kr
Is Cytokinetics Incorporated stock entering bullish territoryQuarterly Trade Report & Precise Swing Trade Alerts - Newser
What to expect from Cytokinetics Incorporated in the next 30 daysSell Signal & Verified Stock Trade Ideas - Newser
Using Ichimoku Cloud for Cytokinetics Incorporated technicalsQuarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Relative strength of Cytokinetics Incorporated in sector analysisPortfolio Risk Report & Intraday High Probability Alerts - Newser
1.04%
7.45%
자본화:
|
볼륨(24시간):